NASDAQ:AMPH

Amphastar Pharmaceuticals Stock News

NASDAQ Stock Exchange > Healthcare > Drug Manufacturers—Specialty & Generic

$40.17

+0.160 (+0.400%)

At Close: Apr 22, 2024

Are Medical Stocks Lagging Amphastar Pharmaceuticals (AMPH) This Year?

11:17am, Tuesday, 10'th Oct 2023

Here is how Amphastar Pharmaceuticals (AMPH) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year.

Amphastar Pharmaceuticals (AMPH) Rises Higher Than Market: Key Facts

07:32pm, Monday, 09'th Oct 2023

In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $47.55, denoting a +0.76% change from the preceding trading day.

Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference

04:05pm, Thursday, 31'st Aug 2023

RANCHO CUCAMONGA, CA / ACCESSWIRE / August 31, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operati

Amphastar Pharma (AMPH) Stock Skyrockets 89% YTD: Here's Why

03:34pm, Friday, 18'th Aug 2023

Amphastar Pharma (AMPH) shares are up 89.1% year to date due to the acquisition of Baqsimi from Lilly. The company also receives FDA approval for Naloxone.

Is Amphastar (AMPH) a Solid Growth Stock? 3 Reasons to Think "Yes"

01:47pm, Friday, 11'th Aug 2023

Amphastar (AMPH) could produce exceptional returns because of its solid growth attributes.

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

12:17pm, Friday, 11'th Aug 2023

The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to AMPH, RDY and TEVA.

Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates

09:56pm, Tuesday, 08'th Aug 2023

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.39 per share a year ago.

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2023 Earnings Call Transcript

08:35pm, Tuesday, 08'th Aug 2023

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Dan Dischner - Senior Vice President of Corporate Communications Bill Pet

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

04:10pm, Wednesday, 02'nd Aug 2023

RANCHO CUCAMONGA, CA / ACCESSWIRE / August 2, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2023 ended June 30, 2023, a

Amphastar Pharmaceuticals (AMPH) is a Great Momentum Stock: Should You Buy?

01:10pm, Wednesday, 26'th Jul 2023

Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.

5 Must-Buy High-Flying Mid-Caps to Enhance Your Portfolio

10:37am, Wednesday, 19'th Jul 2023

We have narrowed our search to five mid-cap stocks with more than 50% returns year to date. These are: PGTI, SHAK, IDCC, ANF, AMPH.

Amphastar (AMPH) is an Incredible Growth Stock: 3 Reasons Why

02:04pm, Wednesday, 12'th Jul 2023

Amphastar (AMPH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Profitable Stocks Worth Investing in Using Net Income Ratio

10:08am, Friday, 07'th Jul 2023

PDD Holdings (PDD), Amphastar Pharmaceuticals (AMPH) and Suzano (SUZ) are some of the top picks with a high net income ratio.

Amphastar Pharmaceuticals (AMPH) Is Up 0.54% in One Week: What You Should Know

01:02pm, Wednesday, 05'th Jul 2023